B Oliva

1.1k total citations
33 papers, 900 citations indexed

About

B Oliva is a scholar working on Molecular Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, B Oliva has authored 33 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Medicine, 13 papers in Molecular Biology and 11 papers in Infectious Diseases. Recurrent topics in B Oliva's work include Antibiotic Resistance in Bacteria (15 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Mycobacterium research and diagnosis (6 papers). B Oliva is often cited by papers focused on Antibiotic Resistance in Bacteria (15 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Mycobacterium research and diagnosis (6 papers). B Oliva collaborates with scholars based in Italy, United Kingdom and United States. B Oliva's co-authors include Ian Chopra, Alex J. O’Neill, I. Chopra, Paolo Aureli, Anna Maria Ferrini, Keith Miller, George A. Ellestad, Robert Cassels, Peter J. O’Hanlon and Donald P. Knowles and has published in prestigious journals such as Journal of Bacteriology, Antimicrobial Agents and Chemotherapy and Journal of Chromatography A.

In The Last Decade

B Oliva

31 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Oliva Italy 17 379 207 203 182 156 33 900
Raymond Legrand France 12 418 1.1× 314 1.5× 164 0.8× 74 0.4× 156 1.0× 14 893
Sophie Brinster France 11 322 0.8× 231 1.1× 116 0.6× 122 0.7× 77 0.5× 11 644
Barry Barton United Kingdom 11 534 1.4× 125 0.6× 460 2.3× 124 0.7× 384 2.5× 12 1.0k
Z Markiewicz Poland 15 244 0.6× 111 0.5× 162 0.8× 160 0.9× 96 0.6× 48 805
Anne Berscheid Germany 14 645 1.7× 235 1.1× 108 0.5× 169 0.9× 228 1.5× 23 1.1k
Michael A. D’Elia Canada 11 505 1.3× 228 1.1× 154 0.8× 64 0.4× 147 0.9× 13 784
Dobryan M. Tracz Canada 16 257 0.7× 326 1.6× 292 1.4× 342 1.9× 71 0.5× 26 979
John Pace United States 19 459 1.2× 618 3.0× 307 1.5× 375 2.1× 362 2.3× 30 1.7k
G. Seltmann Germany 12 236 0.6× 205 1.0× 127 0.6× 138 0.8× 32 0.2× 74 720
Saı̈d Jabbouri France 17 858 2.3× 372 1.8× 92 0.5× 110 0.6× 63 0.4× 27 1.5k

Countries citing papers authored by B Oliva

Since Specialization
Citations

This map shows the geographic impact of B Oliva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Oliva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Oliva more than expected).

Fields of papers citing papers by B Oliva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Oliva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Oliva. The network helps show where B Oliva may publish in the future.

Co-authorship network of co-authors of B Oliva

This figure shows the co-authorship network connecting the top 25 collaborators of B Oliva. A scholar is included among the top collaborators of B Oliva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Oliva. B Oliva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santino, Iolanda, et al.. (2006). Genotype and Phenotype Relationship in MLSB Resistance in Streptococcus Pyogenes and Streptococcus Agalactiae Isolated in Central Italy. International Journal of Immunopathology and Pharmacology. 19(4). 889–895. 2 indexed citations
2.
Pontieri, Eugenio, Clementina Caracciolo, T Ceddia, et al.. (2005). Genetic Variability among Blastoschizomyces Capitatus Isolates from Different Clinical Sources. International Journal of Immunopathology and Pharmacology. 18(3). 531–539. 3 indexed citations
3.
Oliva, B. (2004). Anti-staphylococcal activity and mode of action of clofazimine. Journal of Antimicrobial Chemotherapy. 53(3). 435–440. 46 indexed citations
4.
O’Neill, Alex J., Keith Miller, B Oliva, & Ian Chopra. (2004). Comparison of assays for detection of agents causing membrane damage in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 54(6). 1127–1129. 63 indexed citations
5.
Oliva, B, et al.. (2003). Antimycotic activity of Melaleuca alternifolia essential oil and its major components. Letters in Applied Microbiology. 37(2). 185–187. 71 indexed citations
6.
Aureli, Paolo, et al.. (2003). Susceptibility of Listeria monocytogenes isolated from food in Italy to antibiotics. International Journal of Food Microbiology. 83(3). 325–330. 47 indexed citations
7.
Oliva, B, Keith Miller, Alex J. O’Neill, et al.. (2003). Biological Properties of Novel Antistaphylococcal Quinoline-Indole Agents. Antimicrobial Agents and Chemotherapy. 47(2). 458–466. 50 indexed citations
8.
Pourshaban, M., et al.. (2002). Transferable tetracycline resistance in Listeria monocytogenes from food in Italy. Journal of Medical Microbiology. 51(7). 564–597. 23 indexed citations
9.
O’Neill, Alex J., et al.. (2000). RNA Polymerase Inhibitors with Activity against Rifampin-Resistant Mutants of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 44(11). 3163–3166. 76 indexed citations
10.
Oliva, B, et al.. (1995). SB 205952, a novel semisynthetic monic acid analog with at least two modes of action. Antimicrobial Agents and Chemotherapy. 39(9). 1925–1933. 17 indexed citations
11.
Cassels, Robert, B Oliva, & Donald P. Knowles. (1995). Occurrence of the regulatory nucleotides ppGpp and pppGpp following induction of the stringent response in staphylococci. Journal of Bacteriology. 177(17). 5161–5165. 57 indexed citations
12.
Oliva, B, William M. Maiese, Michael Greenstein, Donald B. Borders, & Ian Chopra. (1993). Mode of action of the cyclic depsipeptide antibiotic LL-AO34β1 and partial characterization of a Staphylococcus aureus mutant resistant to the antibiotic. Journal of Antimicrobial Chemotherapy. 32(6). 817–830. 12 indexed citations
13.
Oliva, B & I. Chopra. (1992). Tet determinants provide poor protection against some tetracyclines: further evidence for division of tetracyclines into two classes. Antimicrobial Agents and Chemotherapy. 36(4). 876–878. 32 indexed citations
14.
Rasmussen, B A, H F Noller, Gary Daubresse, et al.. (1991). Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Antimicrobial Agents and Chemotherapy. 35(11). 2306–2311. 76 indexed citations
15.
Oliva, B, et al.. (1990). Broad spectrum β-lactamases of Citrobacter diversus. Journal of Antimicrobial Chemotherapy. 25(3). 335–341. 4 indexed citations
16.
Scazzocchio, F., et al.. (1988). Inhibition of plasmid conjugation by some recently synthetized 4-quinolone compounds.. PubMed. 7(5). 295–7. 3 indexed citations
17.
Amicosante, Gianfranco, et al.. (1987). Fractionation and characterization of two β-lactamases in Citrobacter diversus ULA-27 strain by chromatofocusing. Journal of Chromatography A. 403. 366–372. 9 indexed citations
18.
Ceddia, T, et al.. (1987). Simplified identification of bacteria belonging to the genus Salmonella. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene Series A Medical Microbiology Infectious Diseases Virology Parasitology. 266(3-4). 438–442. 1 indexed citations
19.
Ravagnan, Giampietro, et al.. (1975). <i>In vitro </i>and <i>in vivo </i>Microbiological Evaluation of Cephapirin, a New Antibiotic. Chemotherapy. 21(5). 289–296. 2 indexed citations
20.
Ravagnan, Giampietro, et al.. (1973). The Microbiological Properties of a Dicloxacillin-Hetacillin Combination. Chemotherapy. 19(6). 367–378. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026